VIMOVO (STAT RX USA LLC)
Welcome to the PulseAid listing for the VIMOVO drug offered from STAT RX USA LLC. This Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC],Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA],Cytochrome P450 2C19 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | STAT RX USA LLC |
| NON-PROPRIETARY NAME: | NAPROXEN AND ESOMEPRAZOLE MAGNESIUM |
| SUBSTANCE NAME: | NAPROXEN; ESOMEPRAZOLE MAGNESIUM |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC],Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA],Cytochrome P450 2C19 Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, DELAYED RELEASE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2011-07-01 |
| END MARKETING DATE: | 0000-00-00 |
VIMOVO HUMAN PRESCRIPTION DRUG Details:
| Item Description | VIMOVO from STAT RX USA LLC |
| LABELER NAME: | STAT RX USA LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 375; 20(mg/1; mg/1) |
| START MARKETING DATE: | 2011-07-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 16590-957_e335359e-adbf-42c8-b58e-e93424505d7c |
| PRODUCT NDC: | 16590-957 |
| APPLICATION NUMBER: | NDA022511 |
Other NAPROXEN; ESOMEPRAZOLE MAGNESIUM Pharmaceutical Manufacturers / Labelers:
